Medical Noncontrolling Interest In Consolidated Entity from 2010 to 2025

MPW Stock  USD 5.45  0.06  1.11%   
Medical Properties Noncontrolling Interest In Consolidated Entity yearly trend continues to be fairly stable with very little volatility. Noncontrolling Interest In Consolidated Entity will likely drop to about 1.3 M in 2025. During the period from 2010 to 2025, Medical Properties Noncontrolling Interest In Consolidated Entity regression line of quarterly data had mean square error of 220752.1 T and geometric mean of 0.00. View All Fundamentals
 
Noncontrolling Interest In Consolidated Entity  
First Reported
2011-03-31
Previous Quarter
1.6 M
Current Value
1.6 M
Quarterly Volatility
389.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medical Properties financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Properties' main balance sheet or income statement drivers, such as Depreciation And Amortization of 476.4 M, Interest Expense of 351.6 M or Selling General Administrative of 127.1 M, as well as many indicators such as Price To Sales Ratio of 2.26, Dividend Yield of 0.14 or PTB Ratio of 0.47. Medical financial statements analysis is a perfect complement when working with Medical Properties Valuation or Volatility modules.
  
Build AI portfolio with Medical Stock
Check out the analysis of Medical Properties Correlation against competitors.

Latest Medical Properties' Noncontrolling Interest In Consolidated Entity Growth Pattern

Below is the plot of the Noncontrolling Interest In Consolidated Entity of Medical Properties Trust over the last few years. It is Medical Properties' Noncontrolling Interest In Consolidated Entity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medical Properties' overall financial position and show how it may be relating to other accounts over time.
Noncontrolling Interest In Consolidated Entity10 Years Trend
Slightly volatile
   Noncontrolling Interest In Consolidated Entity   
       Timeline  

Medical Noncontrolling Interest In Consolidated Entity Regression Statistics

Arithmetic Mean239,445,287
Geometric Mean0.00
Coefficient Of Variation213.01
Mean Deviation382,216,642
Median4,997,000
Standard Deviation510,047,907
Sample Variance260148.9T
Range1.4B
R-Value(0.46)
Mean Square Error220752.1T
R-Squared0.21
Significance0.08
Slope(48,860,655)
Total Sum of Squares3902233T

Medical Noncontrolling Interest In Consolidated Entity History

20251.3 M
20241.4 M
20221.6 M
20215.5 M
20205.3 M
2019107 K
201813.8 M

About Medical Properties Financial Statements

Medical Properties investors use historical fundamental indicators, such as Medical Properties' Noncontrolling Interest In Consolidated Entity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medical Properties. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Noncontrolling Interest In Consolidated Entity1.4 M1.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medical Stock Analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.